Trials / Not Yet Recruiting
Not Yet RecruitingNCT06370949
The Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block
Comparison of the Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block in Colorectal Cancer Surgery
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (estimated)
- Sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Transversus abdominis plane (TAP) block is an anesthesia method that provides somatic analgesia to the anterior and lateral abdominal walls. Thus, TAP block is widely implemented in perioperative management of colorectal cancer patients. Researchers aimed to evaluate the analgesic effectiveness and duration of effect of dexmedetomidine added to bupivacaine in the TAP block applied in colorectal cancer surgeries.
Detailed description
Transversus abdominis plane (TAP) block is an anesthesia method that provides somatic analgesia to the anterior and lateral abdominal walls. With the increasing use of ultrasound guidance during peripheral nerve blocks, trunk blocks such as the transversus abdominis plane (TAP) block are widely used for analgesia after abdominal surgery. The advantages of TAP block include being less invasive than epidural analgesia, lower incidence of hypotension, and shorter hospital stay. Due to these advantages, TAP block has become a widely preferred method. Researchers aimed to evaluate the analgesic effectiveness and duration of effect of dexmedetomidine added to bupivacaine in the TAP block applied in colorectal cancer surgeries. The study will be conducted in a tertiary oncology hospital in Turkey and 84 colorectal cancer patients will be included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacain | Ultrasonography (USG) guided bilateralTAP block:20 ml %0,25 concentration bupivacain |
| DRUG | bupivacain+dexmedetomidine | Ultrasonography (USG) guided bilateral TAP block: 20 ml %0,25 concentration bupivacain+ 0.5 mcg/kg dexmedetomidine |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-09-30
- Completion
- 2024-11-30
- First posted
- 2024-04-17
- Last updated
- 2024-04-17
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06370949. Inclusion in this directory is not an endorsement.